These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 17445226)
1. Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo. Nosheny RL; Ahmed F; Yakovlev A; Meyer EM; Ren K; Tessarollo L; Mocchetti I Eur J Neurosci; 2007 Apr; 25(8):2275-84. PubMed ID: 17445226 [TBL] [Abstract][Full Text] [Related]
2. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra. Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504 [TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death. Nosheny RL; Bachis A; Acquas E; Mocchetti I Eur J Neurosci; 2004 Dec; 20(11):2857-64. PubMed ID: 15579139 [TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system. Mocchetti I; Nosheny RL; Tanda G; Ren K; Meyer EM Ann N Y Acad Sci; 2007 Dec; 1122():144-54. PubMed ID: 18077570 [TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor inhibits human immunodeficiency virus-1/gp120-mediated cerebellar granule cell death by preventing gp120 internalization. Bachis A; Major EO; Mocchetti I J Neurosci; 2003 Jul; 23(13):5715-22. PubMed ID: 12843275 [TBL] [Abstract][Full Text] [Related]
6. Brain-derived neurotrophic factor modulates expression of chemokine receptors in the brain. Ahmed F; Tessarollo L; Thiele C; Mocchetti I Brain Res; 2008 Aug; 1227():1-11. PubMed ID: 18588860 [TBL] [Abstract][Full Text] [Related]
7. Semisynthetic sphingoglycolipid LIGA20 is neuroprotective against human immunodeficiency virus-gp120-mediated apoptosis. Bachis A; Mocchetti I J Neurosci Res; 2006 Apr; 83(5):890-6. PubMed ID: 16477610 [TBL] [Abstract][Full Text] [Related]
8. Axonal transport of human immunodeficiency virus type 1 envelope protein glycoprotein 120 is found in association with neuronal apoptosis. Bachis A; Aden SA; Nosheny RL; Andrews PM; Mocchetti I J Neurosci; 2006 Jun; 26(25):6771-80. PubMed ID: 16793884 [TBL] [Abstract][Full Text] [Related]
9. M-tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T-tropic gp120 in rat striatum. Bachis A; Cruz MI; Mocchetti I Eur J Neurosci; 2010 Aug; 32(4):570-8. PubMed ID: 20670282 [TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor is neuroprotective against human immunodeficiency virus-1 envelope proteins. Bachis A; Mocchetti I Ann N Y Acad Sci; 2005 Aug; 1053():247-57. PubMed ID: 16179530 [TBL] [Abstract][Full Text] [Related]
11. Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model. Tripanichkul W; Gerdprasert O; Jaroensuppaperch EO Int J Neurosci; 2010 Jul; 120(7):489-95. PubMed ID: 20583901 [TBL] [Abstract][Full Text] [Related]
12. The retrograde delivery of adenovirus vector carrying the gene for brain-derived neurotrophic factor protects neurons and oligodendrocytes from apoptosis in the chronically compressed spinal cord of twy/twy mice. Uchida K; Nakajima H; Hirai T; Yayama T; Chen K; Guerrero AR; Johnson WE; Baba H Spine (Phila Pa 1976); 2012 Dec; 37(26):2125-35. PubMed ID: 22648027 [TBL] [Abstract][Full Text] [Related]
13. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice. Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572 [TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons. Mocchetti I; Bachis A; Nosheny RL; Tanda G Neurotox Res; 2007 Sep; 12(2):135-43. PubMed ID: 17967737 [TBL] [Abstract][Full Text] [Related]
18. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease. Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433 [TBL] [Abstract][Full Text] [Related]
19. Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120). Biard-Piechaczyk M; Robert-Hebmann V; Richard V; Roland J; Hipskind RA; Devaux C Virology; 2000 Mar; 268(2):329-44. PubMed ID: 10704341 [TBL] [Abstract][Full Text] [Related]
20. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]